Exponent (EXPO) is Initiated by Cantor Fitzgerald to Buy

Exponent (EXPO) was Initiated by Cantor Fitzgerald to “Buy”. Cantor Fitzgerald advised their investors in a research report released on Aug 26, 2016.

Many Wall Street Analysts have commented on Exponent. Exponent was Initiated by Avondale to “Mkt Perform” on Jul 7, 2016.

On the company’s financial health, Exponent reported $0.38 EPS for the quarter, missing the analyst consensus estimate by $ -0.05 based on the information available during the earnings call on Jul 19, 2016. Analyst had a consensus of $0.43. The company had revenue of $73.33 million for the quarter, compared to analysts expectations of $77.96 million. The company’s revenue was down -2.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.43 EPS.

Exponent opened for trading at $49.23 and hit $50.15 on the upside on Tuesday, eventually ending the session at $50.11, with a gain of 1.83% or 0.9 points. The heightened volatility saw the trading volume jump to 1,79,831 shares. Company has a market cap of $1,302 M.

Investors should note that on Jul 19, 2016, Exponent announced a cash dividend of $0.1800. The company’s management has announced Aug 31, 2016 as the ex-dividend date and fixed the record date on Sep 2, 2016. The payable date has been fixed on Sep 23, 2016.

In a different news, on Aug 16, 2016, Paul Boehm (Group Vice President) sold 5,000 shares at $52.18 per share price. According to the SEC, on Aug 16, 2016, Robert D Caligiuri (Group Vice President) sold 1,300 shares at $51.67 per share price. On Jul 18, 2016, Paul R Johnston (President & CEO) sold 5,500 shares at $59.27 per share price, according to the Form-4 filing with the securities and exchange commission.

Exponent Inc. is a science and engineering consulting firm that provides solutions to complex problems. The Company serves clients in automotive aviation chemical construction consumer products energy Government health insurance manufacturing and technology among others. It provides engineering and scientific consulting services to clients around the world. It operates around 22 practices and centers in two operating segments: Engineering and Other Scientific and Environmental and Health. Its Engineering and Other Scientific segment includes biomechanics biomedical engineering buildings and structures construction consulting electrical engineering and computer science engineering management consulting thermal sciences and vehicle analysis services among others. Its Environmental and Health segment includes chemical regulation and food safety ecological and biological sciences environmental and earth sciences and mechanistic biology services among others.


Leave a Reply

Exponent - Is it time to Sell?

Top Brokerage Firms are advising their investors on Exponent. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.